A carregar...

A novel data mining application to detect safety signals for newly approved medications in routine care of patients with diabetes

BACKGROUND: Clinical trials are often underpowered to detect serious but rare adverse events of a new medication. We applied a novel data mining tool to detect potential adverse events of canagliflozin, the first sodium glucose co‐transporter 2 (SGLT2 inhibitor) in the United States, using real‐worl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Endocrinol Diabetes Metab
Main Authors: Fralick, Michael, Kulldorff, Martin, Redelmeier, Donald, Wang, Shirley V., Vine, Seanna, Schneeweiss, Sebastian, Patorno, Elisabetta
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8279599/
https://ncbi.nlm.nih.gov/pubmed/34277962
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.237
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!